Abivax SA American Depositary Shares
Stock Chart, Company Information, and Scan Results
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Abivax SA American Depositary Shares Company Information, Fundamentals, and Technical Indicators
ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.
Abivax SA American Depositary Shares In Our Stock Scanner
As of Aug 25, 2026
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.